ICCM News and Press, IceCure Medical Ltd. From 12/09/21

Gainers: Inspira Technologies (NASDAQ:IINN) +92%. Ensysce Biosciences (NASDAQ:ENSC) +79%. Insignia (NASDAQ:ISIG) +44%. Hovnanian Enterprises (NASDAQ:HOVNP) +33%. American Virtual Cloud Technologies (NASDAQ:AVCT) +31%. Blue Star Foods Corp. (NASDAQ:BSFC) +16%. Hovnanian (NYSE:HO...

Gainers: Inspira Technologies (NASDAQ:IINN) +103%, Ensysce Biosciences (NASDAQ:ENSC) +53%, Jasper Therapeutics (NASDAQ:JSPR) +24%, Ambrx Biopharma (NYSE:AMAM) +17%, iSpecimen (NASDAQ:ISPC) +15%. Losers: Reata Pharmaceuticals (NASDAQ:RETA)...

IceCure Medical (NASDAQ:ICCM) priced an underwritten public offering of 3.31M shares at $3.45/share, pre-funded warrants to purchase up to 1.03M ordinary shares at $3.449/pre-funded warrant. This represents the per share public offering price for the ordinary shares less the $0.001/share exer...

IceCure Medical Ltd. Announces Pricing of $15 Million Underwritten Public Offering PR Newswire CAESAREA, Israel , Dec. 9, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the " Company " or " IceCure "), developer of minimally-in...

IceCure Medical's Interim Results of the ICE3 Clinical Trial for Early-Stage Breast Cancer Cryoablation featured at the 2021 Annual Meeting of the Radiological Society of North America PR Newswire CAESAREA, Israel , Dec. 2, 2021 /PRNewswire/ -- IceCure Medi...

Applied UV (NASDAQ:AUVI) +47%. Skylight Health Group (NASDAQ:SLHG) +27%. Ardelyx (NASDAQ:ARDX) +18%. IceCure Medical (NASDAQ:ICCM) +17%. Energy Focus (NASDAQ:EFOI) +17%. Ambarella (NASDAQ:AMBA) +15% on Q3 results VBI Vaccines (NASDAQ:VBIV) +14% wins FDA approval for Hepatitis B vacc...

IceCure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources New executive appointment made commensurate with IceCure's growth related to the increased adoption of its flagship ProSense® Cryoablation System and development of next-generation of...

IceCure Medical (NASDAQ:ICCM): 9M GAAP EPS of $0.249. Revenue of $2.75M (+10.4% Y/Y) Press Release For further details see: IceCure Medical reports 9M results

IceCure Medical Reports Financial Results as of and for the first Nine Months of 2021 and Recent Corporate Developments PR Newswire CAESAREA, Israel , Nov. 23, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), dev...

IceCure Medical Announces New Independent Data Published in the Journal of Cancer Therapy Showing that Percutaneous Cryoablation Presents a Potential Substitute for Lumpectomy for Tumors <15mm using ProSense™ IceCure Medical Announces New Independent Data Published in ...